2) Soaked mammary cancer after surgery 复发或转移性乳腺癌 3) recurrence and metastasis of breast cnacer 乳腺癌术后复发转移 例句>> 4) relapse or metastatic breast cancer 转移或复发性乳腺癌 5) recurrent or metastatic breast cancer 复发转移性乳腺癌 ...
Recurrence and metastasis following regional anaesthesia and analgesia for surgery in breast cancer patientsLiu, MStimpson, J
Tamoxifen (TAM) is the most commonly used adjuvant endocrine drug for hormone receptor-positive (HR+) breast cancer patients. However, how to accurately evaluate the risk of breast cancer recurrence and metastasis after adjuvant TAM therapy is still a major concern. In recent years, many studies...
Cancer stem cells (CSCs) have recently attracted great interest because of their emerging role in initiation, progression and metastasis, combined with their intrinsic resistance to chemotherapy and radiation therapy. CSCs and its interaction with hormones in breast cancer are currently being investigated...
Despite being the hallmark of cancer that is responsible for the highest number of deaths, very little is known about the biology of metastasis. Metastatic disease typically manifests after a protracted period of undetectable disease following surgery or
(later confirmed by genetic testing), which meant I carried the BRCA gene mutation, putting me at high risk of a breast cancer recurrence or metastasis and several other cancers, too. Since triple negative is the most aggressive and deadly type of breast cancer, all I knew was I needed it...
Despite marked advances in the treatment of early-stage breast cancer, many women still develop recurrence and metastasis. In addition, 5-10% of breast cancer patients have metastatic disease at presentation. There are two main interventions for metastatic breast cancer: hormone therapy and chemotherap...
For breast cancer specific mortality, death from other causes as the first event was considered as a competing risk. For death from other causes, breast cancer specific death as the first event was considered as a competing risk. For loco-regional recurrence and metastasis, death from any cause...
Our results show that the porous PDMS drug delivery system effectively inhibits triple negative breast cancer recurrence and metastasis assessment. Thus, no tumor regrowth was observed (after 6 weeks of drug elution) in the groups that had the drug-eluting devices. In contrast, there was tumor re...
HER2 status measurement is mandatory in cases of invasive BC and recommended in cases of recurrence and metastasis [3,40]. For HER2 assessment, IHC reveals a response based on HER2 overexpression in a score ranging from 0 to 3+, where 0/1+ is considered negative, 3+ is considered positive...